Procedure for the generation of a high producer cell line for the expression of a recombinant anti-cd34 antibody
Abstract
The present invention relates to cell capture assay for the selection of a high producer cell line expressing anti-CD34 antibodies that recognize the CD34 membrane-protein in the cell membrane. The monoclonal antibody secreted by the hybridoma cell line 9C5/9069 binds to human CD34 and is used to isolate stem cells. The DNA sequences encoding for the antibody heavy and light chain have been identified, isolated from the hybridoma cells and cloned into appropriate expression vectors. After co-transfection of the heavy and light chain genes into HEK293T or in CHO cells either conditioned medium or purified antibody were assessed for binding to CD34 protein located in the cell membrane in different cell capture assays. The binding of the antibody to CD34-positive cells could be shown with these assays for several cell lines.
Claims
exact text as granted — not AI-modified1 . A method for generation of a high producer cell line expressing a recombinant anti-CD34 antibody comprising the following steps: (a) selecting cell clones expressing high amounts of the antibody and (b) analyzing the expressed antibodies produced from cell clones in a cell capture assay for binding to CD34+ cells, wherein the cells are HEK293T or CHO cells.
2 . The method according to claim 1 , wherein the cells are adapted to protein free medium.
3 . The method according to claim 1 , wherein the cells are directly grown in protein free medium.
4 . The method according to claim 1 , wherein the cell capture assay is a dose response cell capture assay.
5 . The method according to claim 1 , wherein in that the cell capture assay is a competition cell capture assay.
6 . A method for generation of a high producer cell line expressing a recombinant anti-CD34 antibody comprising the following steps: (a) selecting cell clones expressing high amounts of the antibody and (b) analyzing the expressed antibodies produced from cell clones in a cell capture assay for binding to CD34+ cells, wherein the cells are adapted to protein-free medium or directly grown in protein-free medium.
7 . The method according to claim 6 , wherein the cell capture assay is a dose response cell capture assay.
8 . The method according to claim 6 , wherein in that the cell capture assay is a competition cell capture assay.Join the waitlist — get patent alerts
Track US2013143238A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.